Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 6 of 6 entries
View as:

Treatment With UX007 for a Single Patient With GLUT1 Deficiency Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT02968953 Org: User:
Start: - End: - Due: -

Compassionate Use of Triheptanoin (C7) for Inherited Disorders of Energy Metabolism

Phase: N/A Priority: Normal
NCT ID: NCT01461304 Org: User:
Start: - End: - Due: -

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Pediatric and Adults Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Phase: N/A Priority: Normal
NCT ID: NCT06773026 Org: User:
Start: 07/31/25 End: 02/28/27 Due: 02/28/28

Genome Sequencing in the Intensive Care Unit Population

Phase: N/A Priority: Normal
NCT ID: NCT04848090 Org: User:
Start: 07/13/20 End: 06/30/26 Due: 06/30/27

Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Phase: N/A Priority: Normal
NCT ID: NCT06069375 Org: User:
Start: 04/01/24 End: 12/31/26 Due: 12/31/27

Study of Triheptanoin for the Prevention of Hypoglycemia in Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)

Phase: N/A Priority: Normal
NCT ID: NCT06067802 Org: User:
Start: 07/31/25 End: 07/31/27 Due: 07/31/28